Cargando…
P1436: AGEING IMPACTS HYDROXYCARBAMIDE DOSING IN PATIENTS WITH SICKLE CELL DISEASE
Autores principales: | Doss, Isabelle, Ekong A, Anietie, Stuart-Smith, Sara, Dekreuk, Arne, Azoujibenjamin, Sheila, Seviar, Dale, Gardner, Kate, Kesse-Adu, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430612/ http://dx.doi.org/10.1097/01.HS9.0000972628.14148.90 |
Ejemplares similares
-
P1422: PREVALENCE AND RISK FACTORS FOR RETINOPATHY IN SICKLE CELL DISEASE
por: Gardner, Kate, et al.
Publicado: (2023) -
P1419: A SINGLE CENTRE PERSPECTIVE ON PREGNANCY OUTCOMES AND SICKLE CELL COMPLICATIONS IN WOMEN ON HYDROXYCARBAMIDE PERI-CONCEPTION.
por: Gregori, Maria, et al.
Publicado: (2023) -
5612984 AUDIT OF TRUST COMPLIANCE WITH BSH GUIDELINES FOR UTILISATION OF HYDROXYCARBAMIDE IN PATIENTS WITH SICKLE CELL DISEASE
por: Barker, R., et al.
Publicado: (2023) -
Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease
por: Wiles, NM, et al.
Publicado: (2009) -
P123: A SYSTEMATIC REVIEW OF THE BARRIERS TO UPTAKE AND ADHERENCE TO HYDROXYCARBAMIDE FROM THE PERSPECTIVE OF CHILDREN AND ADULTS WITH SICKLE CELL DISEASE, PARENTS AND CLINICIANS.
por: Clark, C
Publicado: (2022)